 | |
 | |
| Clinical data | |
|---|---|
| Other names | 4-sec-Butylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-sec-butylthiophenethylamine; NIMITZ; Nimitz |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | 10–15 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO2S |
| Molar mass | 269.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
2C-T-17, also known as4-sec-butylthio-2,5-dimethoxyphenethylamine or asNimitz, is apsychedelic drug of thephenethylamine and2C families.[1] It is takenorally.[1]
2C-T-17 was first described in thescientific literature byAlexander Shulgin and colleagues in 1991.[2] Shortly after this, Shulgin described 2C-T-17 in greater detail in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]
According toAlexander Shulgin in his bookPiHKAL (Phenethylamines I Have Known and Loved), 2C-T-17's dose range is 60 to 100 mg and itsduration is 10 to 15 hours.[1] Itsonset is 1 hour and peak effects occurred after 3 hours.[1] 2C-T-17 has been described as a "truly heavy psychedelic" but as producing nopsychedelic visuals and very little in the way ofperceptual changes.[1] User reports described it as having pronouncedpsychoactive effects but had difficulty describing exactly what those effects were.[1]
Thetoxicity of 2C-T-17 is not well-documented.[citation needed] It is much less potent than 2C-T-7, but it may be expected that at very high doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.[citation needed]
Themechanism of action that produces 2C-T-17'shallucinogenic effects has not been specifically established, however it is most likely to result from action as aserotonin5-HT2A receptoragonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.[citation needed]
2C-T-17 is the2 carbonhomologue ofAleph-17, which has never been synthesized.[1] The full chemical name is 2-[4-(2-butylthio)-2,5-dimethoxyphenyl]ethanamine.[1] The drug hasstructural properties similar to drugs in the 2C-T series, with the most closely related compounds being2C-T-7 and2C-T-8.[1]
2C-T-17 was first described in thescientific literature byAlexander Shulgin and colleagues in ajournal article in 1991.[2] Shortly thereafter, it was described in greater detail by Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]
As of October 31, 2016, 2C-T-17 is a controlled substance (Schedule III) in Canada.[3]
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[4]
2C-T-17 is not illegal, but possession and sales of 2C-T-17 could be prosecuted under theFederal Analog Act in theUnited States because of its structural similarities to2C-T-7.
